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Adducin is a ubiquitously expressed membrane skeleton pro-
tein, which consists of either α- and β- or α- and γ-subunits. 
Mutation of the α-adducin gene (ADD1) is linked with 
increased Na+,K+-ATPase activity1,2 and increased renal tubu-
lar sodium reabsorption.3 Variation in the Na+,K+-ATPase 
activity and in the intracellular Na+ concentration might influ-
ence the sodium-dependent transmembranous Ca2+ transport 
in vascular smooth muscle cells and via this mechanism might 
affect arterial tone.4
In the participants of the Flemish Study on Environment, 
Genes and Health Outcomes, interaction between the genes 
encoding ADD1 (Gly460Trp polymorphism), the angiotensin-
converting enzyme, and the angiotensin II type-1 receptor 
influenced the distensibility, cross-sectional compliance, and 
intima-media thickness of the femoral artery.5,6 In the same 
Flemish population7 and in Polish and Russian subjects,8 we 
noticed that blood pressure and the prevalence of hyperten-
sion were associated with the C1797T polymorphism in the 
β-adducin subunit (ADD2), particularly in postmenopausal 
women.7 T allele carriers had significantly higher 24-h systolic 
blood pressure than CC homozygotes.8 Moreover, Cwynar et al. 
reported interaction between the ADD1 Gly460Trp polymor-
phism and the A386G polymorphism in the γ-adducin subunit 
(ADD3).9 Peripheral and central pulse pressures were higher in 
carriers of both the ADD1 Trp allele and the ADD3 G allele.9
To our knowledge, no previous study investigated whether 
arterial properties are related to genetic interactions between 
the three adducin subunits. We addressed this question in the 
participants of the Flemish Study on Environment, Genes and 
Health Outcomes with available ultrasonographically meas-
ured arterial phenotypes.
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Arterial Properties in Relation to Genetic Variations 
in the Adducin Subunits in a White Population
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Tatiana Kuznetsova1, Yu Jin1, Paulo Manunta5, Tom Richart1,3, Harry A. Struijker-Boudier6, Robert Fagard1,  
Jan Filipovský2 and Giuseppe Bianchi5
Background
adducin is a membrane skeleton protein, which consists of either 
α- and β- or α- and γ-subunits. We investigated whether arterial 
characteristics might be related to the genes encoding ADD1 
(Gly460Trp-rs4961), ADD2 (C1797T-rs4984), and ADD3 (IVS11+386A>G-
rs3731566).
Methods
We randomly recruited 1,126 Flemish subjects (mean age, 43.8 years; 
50.3% women). Using a wall-tracking ultrasound system, we 
measured the properties of the carotid, femoral, and brachial 
arteries. We studied multivariate-adjusted phenotype–genotype 
associations, using a population- and family-based approach.
results
In single-gene analyses, brachial diameter was 0.15 mm (P = 0.0022) 
larger, and brachial distensibility and cross-sectional compliance 
were 1.55 × 10–3/kPa (P = 0.013) and 0.017 mm2/kPa (P = 0.0029) 
lower in ADD3 AA than ADD3 GG homozygotes with an additive effect 
of the G allele. In multiple-gene analyses, the association of brachial 
diameter and distensibility with the ADD3 G allele occurred only in 
ADD1 GlyGly homozygotes. Otherwise, the associations between the 
arterial phenotypes in the three vascular beds and the ADD1 or ADD2 
polymorphisms were not significant. In family-based analyses, the 
multivariate-adjusted heritability was 0.52, 0.38, and 0.30 for brachial 
diameter, distensibility, and cross-sectional compliance, respectively 
(P < 0.001). There was no evidence for population stratification  
(0.07 ≤ P ≤ 0.96). Transmission of the mutated ADD3 G allele was 
associated with smaller brachial diameter in 342 informative 
offspring (–0.12 ± 0.04 mm; P = 0.0085) and in 209 offspring, who 
were ADD1 GlyGly homozygotes (–0.14 ± 0.06 mm; P = 0.018).
conclusions
In ADD1 GlyGly homozygotes, the properties of the brachial artery 
are related to the ADD3 (A386G) polymorphism, but the underlying 
mechanism needs further clarification.
Am J Hypertens 2009; 22:21-26 © 2009 American Journal of Hypertension, Ltd.
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Methods
Study population. The Flemish Study on Environment, Genes 
and Health Outcomes is part of the European Project on 
Genes in Hypertension10 and is embedded in the InGenious 
HyperCare Network of Excellence. From August 1985 until 
July 2003, we recruited a random sample of families from a 
geographically defined area in Northern Belgium. The Ethics 
Committee of the University of Leuven approved the study. All 
participants or their parents gave informed written consent. 
The participation rate averaged 64.3%.
Of 1,306 participants, who underwent a vascular ultra-
sound examination,11 1,180 (90.3%) had high-quality images 
obtained at the common-carotid, femoral, and brachial arter-
ies. We excluded 39 participants, because of missing genotypes, 
and seven because of incomplete information on important 
covariates. In addition, we detected eight cases of inconsist-
ency in Mendelian segregation. Thus, the number of subjects 
analyzed totaled 1,126.
Clinical and biochemical measurements. For at least 3 h before 
the examination, the participants refrained from heavy exercise, 
smoking, and alcohol or caffeine-containing beverages. Trained 
nurses measured the subjects’ anthropometric characteristics, 
heart rate and blood pressure. They administered a questionnaire 
to collect information about each participant’s recent medical 
history, smoking and drinking habits, and intake of medications. 
Each subject’s blood pressure was the average of five consecu-
tive readings measured before the ultrasound examination after 
the subjects had rested in the sitting position for at least 5 min. 
Mean arterial pressure was diastolic pressure plus one-third of 
pulse pressure. Hypertension was defined as a blood pressure 
of at least 140 mm Hg systolic or 90 mm Hg diastolic, and/or the 
use of antihypertensive drugs. Body mass index was weight in 
kilograms divided by the square of height in meters.
Arterial measurements. Using a pulsed ultrasound wall-
 tracking system (Wall Track System; Pie Medical, Maastricht, 
The Netherlands), three trained researchers obtained vascular 
measurements at the common-carotid artery 2 cm proximal 
of the carotid bulb, at the femoral artery 1 cm proximal of the 
bifurcation into the profound and superficial branches, and at 
the right brachial artery 2 cm proximal of the antecubital fossa.
During the ultrasound examination, an automated oscillo-
metric device (Dinamap 845; Critikon, Tampa, FL) recorded 
blood pressure at the upper arm at 5-min intervals. As for the 
conventional auscultatory measurements, cuff size was adjusted 
to the circumference of the upper arm.10 Standard cuffs had an 
inflatable bladder of 12 × 24 cm. Larger cuffs had a 15 × 35 cm 
bladder. As described elsewhere,12 the observers used applana-
tion tonometry with a pencil-shaped probe (Millar Instruments, 
Houston, TX) and calibration to mean arterial pressure and 
diastolic blood pressure at the brachial artery to derive the local 
pulse pressure at the other arteries. We computed the distensibil-
ity (DC) and cross-sectional compliance (CC) from the diastolic 
cross-sectional area (A), the systolic increase in cross-sectional 
area (ΔA) and the local pulse pressure (PP) using the formula:13 
DC = (ΔA/A)/PP and CC = ΔA/PP. A and ΔA were calculated 
from diameter (D) and the change in diameter (ΔD) as A = π × 
(D/2)2 and ΔA = π × ((D + ΔD)/2)2 – π × (D/2)2), respectively. 
The intra- observer intra-session variability was <10% for the 
carotid measurements, <5% for the femoral and brachial diam-
eter, and amounted from 10 to 15% for the femoral and brachial 
cross-sectional compliance and distensibility.14 The intra-ob-
server inter-session and inter-observer intra- session variability 
were of the same order of magnitude.14
Genotypes. We extracted DNA from white blood cells. For 
genotyping, we used a 5′ nuclease detection assay implemented 
on an ABI Prism 7700 Sequence Detection System (Applied 
Biosystems, Foster City, CA). Primers, probes, and PCR 
conditions for ADD1 Gly460Trp (rs4961),15 ADD2 C1797T 
(rs4984),7 and ADD3 IVS11+386A>G (rs3731566)9 genotyp-
ing have already been described in detail elsewhere.
Statistical methods. For database management and statistical 
 analyses, we used the SAS software (SAS Institute, Cary, NC), ver-
sion 9.1. We compared means and proportions, using the large 
sample z-test and Fisher’s exact test, respectively. We assessed 
Hardy–Weinberg proportions in unrelated founders, using an 
exact test based on Monte Carlo permutations. Our statistical 
methods also included single and multiple linear regressions. We 
searched for possible covariates of the arterial phenotypes, using a 
stepwise regression procedure with the P values for independent 
variables to enter and to stay in the model set at 0.15. As  covariates, 
table 1 | characteristics of participants
Founders and 
unrelated 
participants  
(n = 430)
Offspring  
(n = 696) P
anthropometry
 Women (%) 219 (50.9) 347 (49.9) 0.76
 age (years) 51.5 ± 12.4 39.0 ± 15.1 <0.0001
 Height (cm) 167.3 ± 9.1 169.4 ± 9.3 0.0002
 Weight (kg) 71.5 ± 12.6 71.1 ± 14.2 0.60
 Body mass index (kg/m2) 25.5 ± 3.6 24.7 ± 4.2 0.0011
 Systolic pressure (mm Hg) 130.5 ± 15.8 124.3 ± 14.4 <0.0001
 Diastolic pressure (mm Hg) 81.8 ± 9.8 77.3 ± 11.0 <0.0001
 Mean arterial pressure  
 (mm Hg)
98.1 ± 10.5 93.0 ± 11.1 <0.0001
 Heart rate (bpm) 62.5 ± 9.9 61.9 ± 9.4 0.34
Questionnaire data
 Hypertensives (n (%)) 173 (40.2) 164 (23.6) <0.0001
 antihypertensive treatment  
 (n (%))
71 (16.5) 76 (10.9) 0.0082
 Current smokers (n (%)) 128 (29.8) 205 (29.4) 0.95
 alcohol intake ≥5 g/day  
 (n (%))
132 (30.7) 365 (52.4) <0.0001
Values are either mean ± s.d. or number (%) of subjects. P values are for the differences 
between founders and unrelated participants compared to offspring. The number of 
founders and unrelated subjects was 187 and 243, respectively.
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we considered observer, sex, age, body mass index, heart rate, 
mean arterial pressure, and binary variables (0,1), coding for cur-
rent smoking, alcohol intake, and use of antihypertensive drugs.
We performed both population- and family-based analy-
ses. In the former approach, we applied a generalization of 
the standard linear model as implemented in the PROC 
MIXED procedure of the SAS package to test the associa-
tions between phenotypes and single-nucleotide polymor-
phisms (SNPs), while accounting for the nonindependence 
of phenotypes within families and adjusting for covariates. 
In the  family-based analyses, we evaluated the within- and 
between-family  components of phenotypic variability, using 
the orthogonal model proposed by Abecasis and colleagues.16 
We implemented the quantitative transmission disequilibrium 
test, using a mixed model with similar adjustments as in popu-
lation-based analyses. The within-family component of pheno-
typic variance exhibits robustness to population stratification.
results
We divided study participants into founders (n = 187) and unre-
lated subjects (n = 243) as compared with offspring (n = 696). 
Subjects in the founders group (mean age 51.5, range 12.6–81.5 
years) were older compared with offspring (39.0; range 10.9–81.0 
years). Table 1 summarizes their demographic characteristics. 
In contrast to founders, more offspring reported alcohol intake. 
In drinkers, the median alcohol  consumption was 10 g per day 
(interquantile range, 4–20). In smokers, median tobacco use was 
14 cigarettes per day (interquantile range, 8–20). Table 2 lists the 
arterial properties by generation and vascular territory. Brachial 
distensibility and cross- sectional compliance were higher in 
founders than in offspring whereas the opposite was the case for 
the corresponding common-carotid and femoral properties.
Table 3 summarizes the genotype and allele frequencies 
for the adducin genes in the whole study population. In the 
founder generation (0.41 < P < 0.67), the genotype frequencies 
complied with Hardy–Weinberg proportions.
Population-based analyses
In stepwise multiple regression, in line with our previous pub-
lications,11 we identified the following covariates as  significant 
table 2 | arterial properties
Characteristics
Founders and 
unrelated 
participants 
(n = 430)
Offspring  
(n = 696) P
Common carotid artery
 Diameter (mm) 7.35 ± 0.94 7.04 ± 0.89 <0.0001
 Pulse pressure (mm Hg) 48.4 ± 13.5 47.2 ± 12.1 0.13
 Distensibility (10–3/kPa) 21.4 ± 10.2 28.9 ± 14.1 <0.0001
 Cross-sectional compliance  
 (mm2/kPa)
0.89 ± 0.39 1.09 ± 0.45 <0.0001
Femoral artery
 Diameter (mm) 9.24 ± 1.39 9.16 ± 1.57 0.36
 Pulse pressure (mm Hg) 53.0 ± 13.0 52.2 ± 12.9 0.33
 Distensibility (10–3/kPa) 9.0 ± 5.6 11.5 ± 7.3 <0.0001
 Cross-sectional compliance  
 (mm2/kPa)
0.58 ± 0.35 0.73 ± 0.45 <0.0001
Brachial artery
 Diameter (mm) 4.28 ± 0.83 4.36 ± 0.85 0.10
 Pulse pressure (mm Hg) 48.8 ± 10.8 48.3 ± 9.3 0.45
 Distensibility (10–3/kPa) 16.3 ± 11.4 10.8 ± 10.3 <0.0001
 Cross-sectional compliance  
 (mm2/kPa)
0.21 ± 0.14 0.15 ± 0.13 <0.0001
Values are mean ± s.d. P values are for the differences between founders and unrelated 
participants compared to offspring.
table 3 | allele and genotype frequencies
Gene Allele Genotype
ADD1 Gly Trp GlyGly GlyTrp TrpTrp
1,722 (76.53) 530 (23.5) 666 (59.2) 390 (34.6) 70 (6.2)
ADD2 C T CC CT TT
2,000 (88.8) 252 (11.2) 888 (78.9) 224 (19.9) 14 (1.2)
ADD3 A G AA AG GG
1,297 (57.6) 955 (42.4) 388 (34.4) 521 (46.3) 217 (19.3)
Values indicate number of alleles or genotypes (%).
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Figure 1 | Diameter, distensibility, and cross-sectional compliance of the brachial artery in relation to the ADD3 A386G polymorphism. The analyses were 
adjusted for observer, sex, age, body mass index, mean arterial pressure, heart rate, smoking, alcohol intake, and the use of antihypertensive drugs and account 
for family clusters. Values are least square means ± s.e. The number of subjects contributing to each plotted point is given. P values are for linear trend across the 
ADD3 genotypes.
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determinants of one or more of the arterial phenotypes in the 
three vascular beds under study: sex, age, body mass index, 
mean arterial pressure, heart rate, smoking, daily alcohol 
intake in excess of 5 g, and use of antihypertensive drugs. We 
adjusted all phenotype–genotype associations for these covari-
ates, and in addition for observer.
In single-gene analyses (Figure 1), brachial diameter was 
0.15 mm (95% confidence interval (CI), 0.05–0.24; P = 0.0022) 
larger, and brachial distensibility and cross-sectional com-
pliance were 1.55 × 10–3/kPa (CI, 0.33–2.77; P = 0.013) and 
0.017 mm2/kPa (CI, 0.002–0.032; P = 0.0029) lower in ADD3 
AA homozygotes than in their GG counterparts. As shown by 
the P values for linear trend, the G allele had an additive effect 
in relation to these phenotypes. In single-gene analyses, we did 
not find any other significant association between the arterial 
phenotypes under study in the three vascular beds and the 
ADD1 (P ≥ 0.26) or ADD2 (P ≥ 0.27) polymorphisms.
In multiple-gene analyses, there was a significant gene–gene 
interaction between ADD1 and ADD3 in relation to the diam-
eter of the brachial artery (P = 0.042; Figure 2). In carriers of 
the wild-type ADD1, brachial diameter was 0.23 mm (CI, 0.11–
0.34; P = 0.0001) larger in ADD3 AA homozygotes than in GG 
homozygotes with a significant P value for linear trend (P = 
0.0014). This was not the case in ADD1 Trp allele carriers (P for 
linear trend, 0.55). Furthermore, in carriers of the wild-type 
ADD1, brachial distensibility was 2.54 × 10–3/kPa (CI, 0.95–
4.13; P = 0.0018) lower in ADD3 AA homozygotes than in their 
GG counterparts with a significant P value for trend (P = 0.011). 
Although in ADD1 Trp allele carriers brachial distensibility did 
not change with the ADD3 genotype (P = 0.92), the P value for 
the ADD1-by-ADD3 gene–gene interaction was only 0.26. We 
did not find any significant gene–gene interaction between 
carotid and femoral arterial properties and the adducin subu-
nits polymorphisms. In a sensitivity analysis, from which we 
excluded 147 patients on antihypertensive drugs, we reproduced 
our results for the properties of the brachial artery (Figure 3).
Family-based analyses
Our study sample consisted of 58 pedigrees, of which 27 span-
ned more than two generations, and additionally of 273 unre-
lated subjects. The number of offspring per pedigree was <3 in 
24 pedigrees, ranged from 3 to 8 in 30 families, and amounted 
to >8 in 4 pedigrees.
The multivariate-adjusted heritability estimates, as reported 
by the Abecasis software,16 were 0.52 for the brachial  diameter, 
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Figure 3 | Diameter, distensibility, and cross-sectional compliance of brachial 
artery in relation to the ADD1 Gly460Trp and ADD3 A386G polymorphisms in 
979 untreated subjects. For further explanation, see Figure 1.
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Figure 2 | Diameter, distensibility, and cross-sectional compliance of brachial artery in relation to the ADD1 Gly460Trp and ADD3 A386G polymorphisms. Pint 
indicates the significance of the two-way interaction between ADD1 and ADD3. For further explanation, see Figure 1.
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0.38 for distensibility, and 0.30 for cross-sectional compliance 
(P < 0.001 for all). Abecasis’ orthogonal model did not reveal 
population stratification (0.07 ≤ P ≤ 0.96). In 342 informa-
tive offspring, transmission of the mutated ADD3 G allele was 
associated with a significant decrease in brachial diameter 
(–0.12 ± 0.04 mm; χ2 = 6.99; P = 0.0085). We observed a simi-
lar trend in 209 informative offspring, who were homozygous 
for the ADD1 Gly allele (–0.14 ± 0.06 mm; χ2 = 5.72; P = 0.018). 
For brachial distensibility or cross-sectional compliance, these 
estimates were not significant (0.28 ≤ P ≤ 67).
discussion
The key finding of our study was that brachial diameter 
decreased, while brachial distensibility increased with the 
ADD3 G allele, and that these associations were confined to 
ADD1 GlyGly homozygotes. In the family-based analyses, 
we did not find any evidence for population stratification. 
Transmission of the ADD3 G allele was associated with smaller 
brachial diameter in all informative offspring as well as in off-
spring homozygous for ADD1 Gly allele. ADD1 and ADD2, 
alone or in combination with each other, were not associated 
with the arterial properties in the three arterial beds. This was 
also true for ADD1 and ADD3 in relation to the carotid and 
femoral phenotypes.
Adducin functions within the cell as a tissue-specific het-
erodimer, which consists of either α- and β-subunits or α- and 
γ-subunits. This provides the physiologic and biochemical basis 
for studying the interaction among the three adducin genes, 
which map to different chromosomes.3 To our knowledge, no 
prior study investigated the genetic interactions between the 
three adducin subunits in relation to arterial properties. In the 
present population, we previously demonstrated that interac-
tion between the ADD1, the angiotensin- converting enzyme 
(ACE I/D), and the angiotensin II type-1 receptor (AT1R 
C1166A) polymorphisms modulated the properties of the fem-
oral artery. Indeed, in the presence of the ADD1 460Trp allele, 
femoral intima-media thickness was higher in ACE D carriers 
than II homozygotes.5 Moreover, in ACE DD homozygotes, 
carriers of mutated ADD1 had higher femoral distensibility 
and cross-sectional compliance than those with the wild-type 
ADD1.6
Our epidemiologic study only allows speculation about the 
reasons why there might be an association between the proper-
ties of the brachial artery, a small muscular artery, and the ADD3 
A386G polymorphism. One possible mechanism is that the pol-
ymorphism might affect the neurogenic tone of vascular smooth 
muscle cells. Indeed, in rat models, increased blood pressure 
was associated with a decrease in the hypothalamic  levels of 
γ-adducin mRNA and protein.17,18 Furthermore, inhibition of 
γ-adducin by intracellular delivery of γ-adducin-specific anti-
bodies increased the neuronal firing rate possibly via regulation 
of Na+,-K+-ATPase.17 On the other hand, given that the phe-
notypes representative of two other arterial segments did not 
shown any association with the adducin SNPs, this suggests that 
local mechanisms in the brachial artery, rather than the central 
nervous system, might underlie the demonstrated findings.
We did not find any association between the polymorphisms 
under study and the properties of the elastic carotid artery. 
The central elastic arteries, such as the carotid artery, and the 
more peripheral muscular conduit vessels, including the bra-
chial and femoral arteries, have different properties.19 Going 
from the central to the peripheral arteries, the collagen/elastin 
ratio reverses, vascular smooth muscle cells become the pre-
dominant component of the arterial wall, and the phenotype 
of the vascular smooth muscle cells changes.19 Thus, the effects 
of genetic variation in adducin subunits on different arteries 
must be complex and may depend on the vessel wall compo-
nent that is involved.
Our study should be interpreted within the context of its 
limitations. First, our epidemiologic study demonstrated asso-
ciation of arterial properties with variation in ADD3, but did 
not provide direct information on the mechanisms underlying 
these phenotype–genotype associations. Second, we did not use 
the tagging SNP strategy to investigate genotype–phenotype 
associations. However, we have extensively investigated nucle-
otide and haplotype variation in both ADD1 and ADD3, but 
in experimental studies the additional common SNPs did not 
enhance the phenotype–genotype association, over and beyond 
the single SNPs ADD1 rs4961 and ADD3 rs3731566. We will 
publish these results elsewhere. Therefore, we focused on the 
Gly460Trp polymorphism of the ADD1 gene, because it is func-
tional, increases Na+,K+-ATPase activity,1,2 and is associated 
with various cardiovascular5,6,9 and renal phenotypes.3 The A to 
G substitution in ADD3 is located in intron 11 (IVS11 +386A>G 
–rs3731566).3 Neither previous publications nor genome brow-
ser databases provided any suggestion about the functional role 
of the ADD3 A386G polymorphism. A nucleotide variation 
analysis is needed to elucidate the pattern of linkage disequi-
librium of the entire ADD3 locus and to establish whether this 
intronic common polymorphism is linked with the “causal” 
SNP or is the regulatory variant “per se.” According to the latter 
hypothesis, preliminary data showed that ADD3 mRNA level 
was significantly enhanced in GG homozygotes compared with 
the other genotypes in 39 kidney cortex samples from human 
donors (L.C., unpublished data). Third, arterial measurements 
are quantitative traits prone to measurement error. However, the 
repeatability and reproducibility of the arterial phenotypes col-
lected in the present study is high.14 We adjusted for observer 
bias. Moreover, for the brachial diameter in relation to the ADD3 
and ADD1 polymorphisms, there was consistency between 
the population-based and the family-based analyses. We did 
not find any evidence for population stratification. Fourth, we 
did not adjust significance levels for multiple testing. However, 
arterial diameter, distensibility, and cross-sectional compliance 
are correlated phenotypes. In such case, multiple testing is not 
indicated, because each test does not provide a completely inde-
pendent opportunity for type I error.20
In conclusion, the properties of the brachial artery are 
related to the ADD3 (A386G) polymorphism, particularly in 
ADD1 GlyGly homozygotes. Further clinical observations and 
experimental studies should confirm the present observation 
and eventually clarify the underlying mechanism.
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